Safety and Efficacy of Monotherapy with Fantofarone, a Novel Calcium Channel Antagonist, in Patients with Chronic Stable Angina Pectoris

Author:

Glasser Stephen P.,Singh Steven N.,Humen Dennis P.,

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference5 articles.

1. SR 33557: A slow calcium channel antagonist with a novel site of action;Chatelin;Cardiov Drug Rev,1991

2. SR 3357, a novel calcium entry blocker: II. Interactions with 1,4 dihydropyridine, phenylalkamine and benzothiazepine binding sites in rat heart sarcolemmal membranes;Nokin;J Pharmacol Exp Ther,1990

3. SR 33357, an indolizinsulfone blocker of Ca++ channels: identification of receptor sites and analysis of its mode of action;Schmid;Mol Pharmacol,1989

4. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study;Frishman;J Am Coll Cardiol,1995

5. Selective reduction in heart rate with the sinus node inhibitor zatebradine does not lead to the expected improvements in exercise duration in patients with angina pectoris (abstract);Glasser;J Am Coll Cardiol,1995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3